Showing results (1191-1200 of 4,514) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|January 20, 2018
Telotristat ethyl: a novel agent for the therapy of carcinoid syndrome diarrheaJoseph S Dillon, Chandrikha ChandrasekharanFuture Oncology (London, England)|January 11, 2018
Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: a prospective evaluationVeronica Prati, Fiorella Ruatta, Caterina Aversa, et al.Future Oncology (London, England)|March 27, 2018
Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTECXu Shan Sun, Cécile Michel, Emmanuel Babin, et al.Future Oncology (London, England)|January 17, 2018
Optimizing outcomes in EGFR mutation-positive NSCLC: which tyrosine kinase inhibitor and when?Nicolas GirardFuture Oncology (London, England)|January 24, 2018
A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancerLucia Zanoni, Irene Bossert, Antonella Matti, et al.Future Oncology (London, England)|January 26, 2018
The clinicopathological features and prognosis of tumor MSI in East Asian colorectal cancer patients using NCI panelJianmin Zheng, Bangxing Huang, Xiu Nie, et al.Future Oncology (London, England)|March 29, 2018
De-escalating treatment in the adjuvant setting in HER2-positive breast cancerRomualdo Barroso-Sousa, Pedro Exman, Sara M TolaneyFuture Oncology (London, England)|March 13, 2018
Utilization of radiotherapy and stereotactic body radiation therapy for renal cell cancer in the USAWaqar Haque, Vivek Verma, Gary D Lewis, et al.Future Oncology (London, England)|March 13, 2018
Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?Sabrina Rossi, Vincenzo Di Noia, Laura Tonetti, et al.Future Oncology (London, England)|February 9, 2018
Validating the total illness burden index for prostate cancer (TIBI-CaP) in men with castration-resistant prostate cancer: data from TRUMPETScott C Flanders, Janet Kim, Samuel Wilson, et al.Pageof 452